Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Approved and unapproved use of immunoglobulins in Iceland.

Ólafsdóttir BE, Þorsteinsson DÞ, Einarsdóttir R, Lúðvíksson BR, Gröndal G, Erlendsson K, Haraldsson Á.

J Allergy Clin Immunol. 2013 Jun;131(6):1703-5. doi: 10.1016/j.jaci.2013.03.022. Epub 2013 Apr 28. No abstract available.

PMID:
23632300
2.

[Clinical research center at Landspitali -University Hospital].

Erlendsson K.

Laeknabladid. 2010 Mar;96(3):155. doi: 10.17992/lbl.2010.03.276. Icelandic. No abstract available.

PMID:
20197592
3.

Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus.

Kristjansdottir H, Steinsson K, Gunnarsson I, Gröndal G, Erlendsson K, Alarcón-Riquelme ME.

Arthritis Rheum. 2010 Jun;62(6):1702-11. doi: 10.1002/art.27417.

4.

Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families.

Kristjansdottir H, Saevarsdottir S, Gröndal G, Alarcón-Riquelme ME, Erlendsson K, Valdimarsson H, Steinsson K.

Arthritis Rheum. 2008 Dec;58(12):3865-72. doi: 10.1002/art.24129.

5.
6.

C4A deficiency and elevated level of immune complexes: the mechanism behind increased susceptibility to systemic lupus erythematosus.

Traustadottir KH, Sigfusson A, Steinsson K, Erlendsson K.

J Rheumatol. 2002 Nov;29(11):2359-66.

PMID:
12415592
7.

Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families.

Gröndal G, Traustadottir KH, Kristjansdottir H, Lundberg I, Klareskog L, Erlendsson K, Steinsson K.

Lupus. 2002;11(7):435-42.

PMID:
12195785
8.

The inheritance of rheumatoid arthritis in Iceland.

Grant SF, Thorleifsson G, Frigge ML, Thorsteinsson J, Gunnlaugsdóttir B, Geirsson AJ, Gudmundsson M, Vikingsson A, Erlendsson K, Valsson J, Jónsson H, Gudbjartsson DF, Stefánsson K, Gulcher JR, Steinsson K.

Arthritis Rheum. 2001 Oct;44(10):2247-54.

9.
10.

An enzyme based assay for the measurement of complement mediated binding of immune complexes to red blood cells.

Rafnar BO, Traustadóttir KH, Sigfússon A, Arason GJ, Valdimarsson H, Erlendsson K.

J Immunol Methods. 1998 Feb 1;211(1-2):171-81.

PMID:
9617841
11.
12.

[The epidemiology of AIDS in Iceland. The first ten years.].

Briem H, Thorsteinsson SB, Gudmundsson S, Erlendsson K, Love A.

Laeknabladid. 1996 Jan;82(1):21-31. Icelandic.

PMID:
20065388
13.

A study of the major histocompatibility complex in a Caucasian family with multiple cases of systemic lupus erythematosus: association with the C4AQ0 phenotype.

Steinsson K, Arnason A, Erlendsson K, Fossdal R, Skaftadóttir I, Jónsdóttir S, Fjalarson M, Thorsteinsson J.

J Rheumatol. 1995 Oct;22(10):1862-6.

PMID:
8991982
14.

[Diffuse connective tissue diseases (DCTD)--a review].

Steinsson K, Erlendsson K.

Nord Med. 1994;109(8-9):231-5. Review. Swedish.

PMID:
7937032
15.

Splenic uptake of immune complexes in man is complement-dependent.

Davies KA, Erlendsson K, Beynon HL, Peters AM, Steinsson K, Valdimarsson H, Walport MJ.

J Immunol. 1993 Oct 1;151(7):3866-73.

PMID:
8376807
17.

Reciprocal changes in complement activity and immune-complex levels during plasma infusion in a C2-deficient SLE patient.

Erlendsson K, Traustadóttir K, Freysdóttir J, Steinsson K, Jónsdóttir I, Valdimarsson H.

Lupus. 1993 Jun;2(3):161-5.

PMID:
8369807
18.

Disease manifestations in patients with isolated elevation of IgA rheumatoid factor.

Lúthvíksson BR, Jónsson T, Erlendsson K, Sigfússon A.

Scand J Rheumatol. 1992;21(1):1-4.

PMID:
1570479
20.
21.

Intraventricular gamma-globulin for the management of enterovirus encephalitis.

Dwyer JM, Erlendsson K.

Pediatr Infect Dis J. 1988 May;7(5 Suppl):S30-3. Review.

PMID:
2456508
22.

Successful reversal of echovirus encephalitis in X-linked hypogammaglobulinemia by intraventricular administration of immunoglobulin.

Erlendsson K, Swartz T, Dwyer JM.

N Engl J Med. 1985 Feb 7;312(6):351-3. No abstract available.

PMID:
4038544

Supplemental Content

Loading ...
Support Center